Charles River Laboratories International (CRL) Revenue — Quarter Ended Sep 27, 2025
Revenue for the reporting quarter declined compared with the prior quarter and also compared with the same period a year ago. The decrease reflects a continuation of the recent pattern of volatility in quarterly revenue.
Key takeaway
Quarter ended Sep 27, 2025 · FY2025 Q3
Revenue for the reporting quarter declined compared with the prior quarter and also compared with the same period a year ago. The decrease reflects a continuation of the recent pattern of volatility in quarterly revenue.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1B
Revenue reported for this quarter.
Quarter-over-quarter
-2.6%
Change from the immediately preceding quarter.
Year-over-year
-0.5%
Change from the comparable year-ago quarter.
Trailing four quarters
$4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 28, 2024 | $1B | -1.1% |
| Mar 29, 2025 | $984.2M | -2.7% |
| Jun 28, 2025 | $1B | +0.6% |
| Sep 27, 2025 | $1B | -0.5% |
Revenue performance
The reported revenue fell from the level of the immediately preceding quarter.
Quarterly comparison
Compared with the same quarter one year earlier, revenue also decreased.
What to watch
The sequential decline follows a slight increase in the prior quarter, marking a reversal in the near-term trend.